PRECIOUS NEWS | ISSUE 4 | 10/2017
 
 
Link to website
 
 
PRECIOUS NEWS | ISSUE 4 | 10/2017
 
 

Content

Trial progress

In July 2017, the team in Greece managed to obtain national ethics approval! Local approvals are expected shortly. Many thanks to our Greek colleagues for their hard work!

In the UK, the first two hospitals are now open for recruitment (Calderdale Royal Hospital and Sherwood Forest Hospital). Calderdale Royal Hospital already recruited their first two patients within weeks after the SIV (Site Initiation Visit). Two other hospitals in the UK also have had their SIV (Yeovil District Hospital and Kings College Hospital), and will be open to recruitment soon. Bridget Colam in Edinburgh has been of great help in accomplishing this.

We are very happy to announce that the first patients have been recruited in the University Medical Center Hamburg (DE), Academic Medical Center Amsterdam and Haga Hospital the Hague (NL).

Also, the recruitment in IRCCS Instituto Clinico Humanitas (IT) has started, and additional SIVs have been performed at Oslo University Hospital (NO) and East Tallinn Central Hospital (EE).

We thank all sites that have included patients over the past months for their achievement!

Total number of patients included: 61

PRECIOUS on tour

Trial manager Jeroen de Jonge (UMC) will be visiting several PRECIOUS sites throughout Europe to support the start of PRECIOUS. If you think this could be useful for your site as well, please contact the PRECIOUS team ().


Bart van der Worp met with László Csiba, Csilla Vér and other PRECIOUS investigators in Hungary at the meeting of the Hungarian Stroke Society in Györ on 6 October 2017. 

 

Contact

Coordinator

University Medical Center Utrecht, The Netherlands
Dr. Bart van der Worp

Project Management

ARTTIC, Germany
Sophie Rau

 

Follow us on Twitter!
 
 
PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.
The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.		 Copyright | Imprint PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.<br>The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
 

If you no longer wish to receive our newsletter please click here to unsubscribe.

Having trouble viewing this email? Click here to view it in your browser.